Tasal, AbdurrahmanDEMİR, MESUTKANADAŞI, MEHMETBACAKSIZ, AHMETVatankulu, Mehmet AkifSahin, Durmus YildirayEker, Rabia AkilliBOZKURT, ABDİAcarturk, Esmeray2020-10-222020-10-222014-02-01Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , Eker R. A. , BOZKURT A., Acarturk E., -Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure-, MEDICAL SCIENCE MONITOR, cilt.20, 2014http://hdl.handle.net/20.500.12645/24231Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.info:eu-repo/semantics/openAccessArticleWOS:0003319335000018489669579310.12659/msm.88976724549281